Choline kinase is a novel oncogene that potentiates RhoA-induced carcinogenesis.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Cancer Research

• Publication date

  2005-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-04-4416PMID 15994937
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Superfamily of ras-Related Genes

  2012cited by this paper
• Rho GTPase expression in tumourigenesis: Evidence for a significant link

  2005cited by this paper
• Inhibition of choline kinase renders a highly selective cytotoxic effect in tumour cells through a mitochondrial independent mechanism.

  2005cited by this paper
• Molecular Basis for Rho GTPase Signaling Specificity

  2004cited by this paper
• Choline Kinase Activation Is a Critical Requirement for the Proliferation of Primary Human Mammary Epithelial Cells and Breast Tumor Progression

  2004cited by this paper
• Rho GTPases in human cancer: an unresolved link to upstream and downstream transcriptional regulation.

  2004cited by this paper
• Rho-family GTPases: it's not only Rac and Rho (and I like it)

  2004cited by this paper
• Structure and function of choline kinase isoforms in mammalian cells.

  2004cited by this paper
• Choline kinase inhibition induces the increase in ceramides resulting in a highly specific and selective cytotoxic antitumoral strategy as a potential mechanism of action

  2004cited by this paper
• Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer.

  2003cited by this paper
• Rho GTPases in human carcinogenesis: a tale of excess

  2003cited by this paper
• Phospholipase D and choline kinase: their role in cancer development and their potential as drug targets.

  2003cited by this paper
• RhoA and ROCK Promote Migration by Limiting Membrane Protrusions*

  2003cited by this paper
• ROCK and nuclear factor-kappaB-dependent activation of cyclooxygenase-2 by Rho GTPases: effects on tumor growth and therapeutic consequences.

  2003cited by this paper
• Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis

  2003cited by this paper
• Inhibition of choline kinase as a specific cytotoxic strategy in oncogene-transformed cells

  2003cited by this paper
• Regulation of choline kinase activity by Ras proteins involves Ral–GDS and PI3K

  2002influential reference
• Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers.

  2002cited by this paper
• Increased choline kinase activity in human breast carcinomas: clinical evidence for a potential novel antitumor strategy

  2002cited by this paper
• Regulation of gene expression by the small GTPase Rho through the ERK6 (p38γ) MAP kinase pathway

  2001influential reference
• Rho signals to cell growth and apoptosis.

  2001influential reference
• Searching new targets for anticancer drug design: the families of Ras and Rho GTPases and their effectors.

  2001cited by this paper
• Choline kinase: a novel target for antitumor drugs.

  2001cited by this paper
• Inhibition of ChoK is an efficient antitumor strategy for Harvey-, Kirsten-, and N-ras-transformed cells.

  2001cited by this paper
• Regulation of gene expression by the small GTPase Rho through the ERK6 (p38 gamma) MAP kinase pathway.

  2001cited by this paper
• Rho GTPases as early markers for tumour progression.

  2001cited by this paper
• In vivo antitumor activity of choline kinase inhibitors: a novel target for anticancer drug discovery.

  1999cited by this paper
• RhoA effector mutants reveal distinct effector pathways for cytoskeletal reorganization, SRF activation and transformation

  1998cited by this paper
• Rho GTPases and signaling networks.

  1997cited by this paper
• Choline kinase inhibitors as a novel approach for antiproliferative drug design

  1997cited by this paper
• Rho proteins induce metastatic properties in vivo

  1997cited by this paper
• Generation of phosphorylcholine as an essential event in the activation of Raf‐1 and MAP‐kinases in growth factors‐induced mitogenic stimulation

  1995cited by this paper
• Early increase in choline kinase activity upon induction of the H-ras oncogene in mouse fibroblast cell lines.

  1995cited by this paper
• Tumorigenic activity of rho genes from Aplysia californica.

  1993cited by this paper
• In vivo 31P MRS of experimental tumours

  1993cited by this paper
• Phosphorylcholine: a novel second messenger essential for mitogenic activity of growth factors.

  1993cited by this paper
• Phospholipid metabolites as indicators of cancer cell function

  1992cited by this paper
• Biological Function of Aplysia californica rho Gene

  1991cited by this paper
• Transformed cells.

  1949cited by this paper

• How Do Hepatocyte MicroRNAs Play a Role in Hepatitis C Virus Replication and Pathogenesis? Emerging Hypotheses and Strategies for MicroRNA Therapeutics and Drug Development

  2025cites this paper
• Choline kinases: Enzymatic activity, involvement in cancer and other diseases, inhibitors

  2024cites this paper
• Prognostic potential of lipid profiling in cancer patients: a systematic review of mass spectrometry-based studies

  2024cites this paper
• Inhibition of choline metabolism in an angioimmunoblastic T-cell lymphoma preclinical model reveals a new metabolic vulnerability as possible target for treatment

  2024cites this paper
• PaSTe. Blockade of the Lipid Phenotype of Prostate Cancer as Metabolic Therapy: A Theoretical Proposal.

  2023cites this paper
• History of Research on Phospholipid Metabolism and Applications to the Detection, Diagnosis, and Treatment of Cancer

  2022cites this paper
• Choline Kinase α Inhibitors MN58b and RSM932A Enhances the Antitumor Response to Cisplatin in Lung Tumor Cells

  2022cites this paper
• DeepTrio: a ternary prediction system for protein–protein interaction using mask multiple parallel convolutional neural networks

  2021cites this paper
• An Update on Molecular Pathways Regulating Vasculogenic Mimicry in Human Osteosarcoma and Their Role in Canine Oncology

  2021cites this paper
• Lipid metabolism part II

  2021cites this paper
• Lipid metabolism part I

  2021cites this paper
• The Mevalonate Pathway, a Metabolic Target in Cancer Therapy

  2021cites this paper
• Involvement of MicroRNA-1-FAM83A Axis Dysfunction in the Growth and Motility of Lung Cancer Cells

  2020cites this paper
• Probe the transport function of ABCA3 by metabolic labelling of choline phospholipids

  2020cites this paper
• The downregulation of choline kinase alpha inhibits clear cell renal cell carcinoma proliferation and metastasis via the MAPK and PI 3 K / AKT pathways

  2019cites this paper
• Functional rescue in a mouse model of congenital muscular dystrophy with megaconial myopathy.

  2019cites this paper
• Molecular basis for the interaction between human choline kinase alpha and the SH3 domain of the c-Src tyrosine kinase

  2019cites this paper
• Untargeted lipidomics reveals specific lipid abnormality in nonfunctioning human pituitary adenomas.

  2019cites this paper
• Choline Kinase Alpha Inhibition by EB-3D Triggers Cellular Senescence, Reduces Tumor Growth and Metastatic Dissemination in Breast Cancer

  2018cites this paper
• Molecular causes of elevated phosphoethanolamine in breast and pancreatic cancer cells

  2018cites this paper
• Identification of a Unique Inhibitor-Binding Site on Choline Kinase α.

  2018cites this paper
• Metabolomic-Based Stratification in Prostate Cancer

  2018cites this paper
• Choline Kinase α Mediates Interactions Between the Epidermal Growth Factor Receptor and Mechanistic Target of Rapamycin Complex 2 in Hepatocellular Carcinoma Cells to Promote Drug Resistance and Xenograft Tumor Progression.

  2017cites this paper
• Choline Kinase Alpha Mediates Interactions Between the Epidermal Growth Factor Receptor and mTORC 2 in Hepatocellular Carcinoma Cells to Promote Drug Resistance and Xenograft Tumor Progression Short Title : Role of CHKA in HCC Progression

  2017cites this paper
• Near infrared fluorescent imaging of choline kinase alpha expression and inhibition in breast tumors

  2017cites this paper
• Overexpression of CHKA contributes to tumor progression and metastasis and predicts poor prognosis in colorectal carcinoma

  2016cites this paper
• Choline kinase alpha-Putting the ChoK-hold on tumor metabolism.

  2016cites this paper
• Human Choline Kinase-α Promotes Hepatitis C Virus RNA Replication through Modulation of Membranous Viral Replication Complex Formation

  2016cites this paper
• Choline Metabolism Alteration: A Focus on Ovarian Cancer

  2016cites this paper
• Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors

  2016cites this paper
• Targeting Phospholipid Metabolism in Cancer

  2016cites this paper
• The metabolic responses to hepatitis B virus infection shed new light on pathogenesis and targets for treatment

  2015cites this paper
• Choline metabolism-based molecular diagnosis of cancer: an update

  2015cites this paper
• Downregulation of Choline Kinase-Alpha Enhances Autophagy in Tamoxifen-Resistant Breast Cancer Cells

  2015cites this paper
• Interplay of choline metabolites and genes in patient-derived breast cancer xenografts

  2014cites this paper
• Direct Inhibition of Choline Kinase by a Near-Infrared Fluorescent Carbocyanine

  2014cites this paper
• Modulation of estrogen and epidermal growth factor receptors by rosemary extract in breast cancer cells

  2014cites this paper
• A new family of choline kinase inhibitors with antiproliferative and antitumor activity derived from natural products

  2014cites this paper
• Metabolomics and transcriptomics demonstrate severe oxidative stress in both localized chemotherapy-treated and bystander tumors.

  2014cites this paper
• Imaging of Tumor Metabolism: MR Spectroscopy

  2014cites this paper
• Evaluación de la expresión de colina-quinasa como factor pronóstico en el carcinoma no microcítico de pulmón

  2014cites this paper
• Choline Kinase β Mutant Mice Exhibit Reduced Phosphocholine, Elevated Osteoclast Activity, and Low Bone Mass*

  2014cites this paper
• Transcriptional regulation and steady-state modeling of metabolic networks

  2013cites this paper
• Methodologies for Metabolomics: Magnetic Resonance Spectroscopy in Investigating the Cancer Metabolome in Preclinical Model Systems

  2013cites this paper
• A non-catalytic role of choline kinase alpha is important in promoting cancer cell survival

  2013cites this paper
• Antiplasmodial Activity and Mechanism of Action of RSM-932A, a Promising Synergistic Inhibitor of Plasmodium falciparum Choline Kinase

  2013cites this paper
• Investigation of positron emission tomography for pharmacological assessment of epidermal growth factor receptor-directed therapies

  2013cites this paper
• Variants in phospholipid metabolism and upstream regulators and non-small cell lung cancer susceptibility

  2013cites this paper
• The fat side of prostate cancer.

  2013cites this paper
• Kinetic and mechanistic characterisation of Choline Kinase-α.

  2013cites this paper
• The role of choline in prostate cancer.

  2012cites this paper
• Sensitization of (colon) cancer cells to death receptor related therapies

  2012cites this paper
• Lipid metabolism in cancer

  2012cites this paper
• Balance of human choline kinase isoforms is critical for cell cycle regulation

  2012cites this paper
• Design, synthesis, theoretical calculations and biological evaluation of new non-symmetrical choline kinase inhibitors.

  2012cites this paper
• ras-induced Up-regulation of CTP:Phosphocholine Cytidylyltransferase α Contributes to Malignant Transformation of Intestinal Epithelial Cells*

  2012cites this paper
• Stable isotope-resolved metabolomics and applications for drug development.

  2012cites this paper
• MRS and MRSI guidance in molecular medicine: targeting and monitoring of choline and glucose metabolism in cancer

  2011cites this paper
• Transcriptomic analysis of Caenorhabditis elegans exposed to nickel (II) acetate using microarray

  2011cites this paper
• CHKA (choline kinase alpha)

  2011cites this paper
• Integrative Systems Biology: Elucidating Complex Traits

  2011cites this paper
• Metabolic tumor imaging using magnetic resonance spectroscopy.

  2011cites this paper
• Choline metabolism in malignant transformation

  2011cites this paper
• Involvement of human choline kinase alpha and beta in carcinogenesis: a different role in lipid metabolism and biological functions.

  2011cites this paper
• A Novel Small Molecule Antagonist of Choline Kinase-α That Simultaneously Suppresses MAPK and PI3K/AKT Signaling

  2011cites this paper
• Loss of 10q26.1-q26.3 in association with 7q34-q36.3 gain or 17q24.3-q25.3 gain predict poor outcome in pediatric medulloblastoma.

  2011cites this paper
• Metabolic Network Topology Reveals Transcriptional Regulatory Signatures of Type 2 Diabetes

  2010cites this paper
• Choline kinase and its function.

  2010cites this paper
• Choline kinase overexpression increases invasiveness and drug resistance of human breast cancer cells

  2010cites this paper
• Magnetic resonance spectroscopy in metabolic and molecular imaging and diagnosis of cancer.

  2010cites this paper
• Selective inhibition of choline kinase simultaneously attenuates MAPK and PI3K/AKT signaling

  2010cites this paper
• Cloning and Activity Analysis of Human Choline Kinase Beta Promoter

  2010cites this paper
• EFFECTS OF CHOLINE KINASE ACTIVITY ON PHOSPHOLIPID METABOLISM AND MALIGNANT PHENOTYPE OF PROSTATE CANCER CELLS

  2010cites this paper
• Mitochondrial bioenergetic background confers a survival advantage to HepG2 cells in response to chemotherapy

  2009cites this paper
• A critical role for choline kinase-α in the aggressiveness of bladder carcinomas

  2009cites this paper
• Regulation of Akt(ser473) phosphorylation by Choline kinase in breast carcinoma cells

  2009cites this paper
• Differential Role of Human Choline Kinase α and β Enzymes in Lipid Metabolism: Implications in Cancer Onset and Treatment

  2009cites this paper
• Stable isotope‐assisted metabolomics in cancer research

  2008cites this paper
• Choline kinase alpha depletion selectively kills tumoral cells.

  2008cites this paper
• Choline kinase as a link connecting phospholipid metabolism and cell cycle regulation: implications in cancer therapy.

  2008influential citation
• Anticuerpos monoclonales anti-colina quinasa alfa y su uso en técnicas analíticas, de diagnóstico del cáncer y en la preparación de medicamentos

  2007cites this paper
• Phosphocholine as a biomarker of breast cancer: Molecular and biochemical studies

  2007cites this paper
• Expression of choline kinase alpha to predict outcome in patients with early-stage non-small-cell lung cancer: a retrospective study.

  2007cites this paper
• Increased lipogenesis in cancer cells: new players, novel targets

  2006cites this paper
• Elucidation of human choline kinase crystal structures in complex with the products ADP or phosphocholine.

  2006cites this paper
• Generation and characterization of monoclonal antibodies against choline kinase alpha and their potential use as diagnostic tools in cancer.

  2006cites this paper